Navigation Links
Brilliant Core Reagent Kits for QPCR and QRT-PCR

DNA sample is derived from a homozygous wild-type, heterozygous, or homozygous mutant individual. One way of calling alleles is by comparing Ct values. In a sample containing the wild-type alleles only, the TET signal should be relatively strong and should appear in earlier amplification cycles (Ct = 26), whereas the FAM signal should be at background level (Ct = 40; Figure 3 ). In the case of a heterozygote, both FAM and TET signals should be seen, but the Ct values should be slightly higher than that for the homozygote wild type or mutant because only one allele each (i.e., the wild-type and the mutant allele) is detected. The Ct values for the heterozygote were 27 (TET) and 27 (FAM) (Figure 3).

Another method for calling alleles is to examine the fluorescence at the last annealing stepin this case, at cycle 40. The final fluorescence provides a qualitative readout because components in the reactions might be limiting at the end of PCR. However, when the proper dilutions of target DNA are included in the reaction, the final fluorescence is often related to the amount of the wild-type or mutant allele in the sample (cycle 40; Figure 3) and can be easily extrapolated by the software of the real-time reader (Table 3). In this analysis, the wild-type sample had a TET signal of 2.2 (normalized endpoint fluorescence), the mutant sample had a FAM signal of 1.34, and the heterozygote showed approximately one-half of the TET or the FAM signal.

FAM (mutant)

'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
2. A Comparison Study of Lipid Tranfection Reagents in A549, NIH 3T3 and COS-7 Cell Lines
3. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
4. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
5. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
6. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
7. TransMessenger Transfection Reagent
8. Effectene Transfection Reagent provides efficient gene delivery to primary neuronal cell cultures
9. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
10. Effectene Transfection Reagent
11. PolyFect Transfection Reagent
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brilliant Core Reagent Kits for QPCR and QRT PCR

(Date:8/21/2008)... NEW YORK, MUNICH, Germany and AMSTERDAM, Neth...thcare and SpePharm Holding, B.V., the,pan-Europea...d that they,have entered into a euro 10 million re...fund SpePharm,s acquisition of Dantrium(R) for Eur...le Pharmaceuticals. At the same,time, TVM Capital,...
(Date:8/20/2008)... VIENNA, Va., Aug. 20 /PRNewswire-USNewswire/ ...0 ranking of the fastest-growing private companies...T) services provider,MicroTech, ranks No. 285 on ... 2008 Inc. 500 list measures revenue growth from 2...U.S.-based, privately held, independent -,no subsi...
(Date:8/20/2008)... INDIANAPOLIS, Ind., Aug. 20 /PRNewswire-First... announced that it has completed the acquisition,o...n Diego-based,biotechnology company focused on dru...y. The completion of the deal followed today,s Spe...SGX stockholders voted in,favor of the merger agre...
(Date:8/20/2008)... Growth Fueled by Popularity with Seniors and ... Marketing, CAMBRIDGE, Mass., Aug. 20 /PRNewswi...hole Health (SWH), a voluntary health care plan fo...ng private company in the,United States., Part of...rowing,companies, SWH had revenue growth of 31,000...
Breaking Biology Technology:TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 2TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 3TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 4TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm 5MicroTech Ranks No. 285 on Inc. Magazine's 2008 List of the 500 Fastest Growing Private Companies in America 2Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3
...f Wisconsin-Madison ,s partnership with Google t...pus libraries could make one of the best historica...users. , ,In the forthcoming months, the popular s...iversity and the Wisconsin Historical Society , w...ble only on shelves and in archives freely accessi...
...dwestern company that works to keep spam out of e-...ts. , ,The e-mail hosting and filtering solutions ... and HostMail that attempt to protect more than...ork appliances that offer protection for up to 30,...uman intelligence-based anti-spam solutions, relea...
... soon will decide whether to change the current lo.... To be patentable, an invention must not be "obvi...ment it was created by the inventor, and any chang...ly impact the ability to procure and enforce paten...ty briefs to appreciate the importance of this cas...
... robust information technology industry, Wisconsin...g to keynoters at this week,s E-Business Best Prac...recent months, information technology executives, ... been shy about the changes they would make. But l...did not cite Jazwiec,s menu of steep income tax cu...
Other Biology Technology:Google to place Wisconsin history online 2Google to place Wisconsin history online 3Google to place Wisconsin history online 4Inventions could fall prey to Monday morning quarterbacking 2Inventions could fall prey to Monday morning quarterbacking 3Inventions could fall prey to Monday morning quarterbacking 4To drive IT, Wisconsin may need entrepreneurial makeover 2To drive IT, Wisconsin may need entrepreneurial makeover 3
(Date:8/20/2008)...leSRO(TM) and MobileCampus(TM) Wireless Data Commu...dministration and Faculty, WALL, N.J., Aug. 20 /P... (OTC Bulletin Board: BKYI), a leader in finger-ba...afety solutions, today announced the,availability ...ure,emergency alert and management solutions for K...
(Date:8/20/2008)...UTH PLAINFIELD, NJ August 20, 2008 New phase 2 d...investigational oral drug PTC124 demonstrates acti...he data show that treatment with PTC124 results in...oride channel function of patients with nonsense-m...ah Hebrew University Hospital in Jerusalem, Israel...
(Date:8/20/2008)...WEST LAFAYETTE, Ind. - Engineers have created a ti...he dexterity of similar devices being ,developed ...nd more ,compact, powerful computer hard drives. ...ght be used as a ,"nanoscale manipulator" that pr... devices also can be used in watery environments f...
(Date:8/20/2008)...USTON (Aug. 20, 2008) The genetic code of a simp... more about how groups of genes function in humans...k in the journal Nature breaks down the genetic ...that one might find anywhere in the world, even in...to identify, in the Trichoplax , genes that are a...
Breaking Biology News(10 mins):BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 2PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 3New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3Genome of saltwater creature could aid understanding of gene grouping 2Keep a Watchful Eye on Sugary Beverage Consumption 9341 1Keep a Watchful Eye on Sugary Beverage Consumption 9341 2Dr Drew Joins the Partnership for a Drug Free America in Supporting TimeToTalk 28TM 29 9338 1Dr Drew Joins the Partnership for a Drug Free America in Supporting TimeToTalk 28TM 29 9338 2Dr Drew Joins the Partnership for a Drug Free America in Supporting TimeToTalk 28TM 29 9338 3Dr Drew Joins the Partnership for a Drug Free America in Supporting TimeToTalk 28TM 29 9338 4Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 1Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 2Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 3Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Cli 1178 4Standard Septic Shock Treatments Ineffective 9335 1Standard Septic Shock Treatments Ineffective 9335 2Standard Septic Shock Treatments Ineffective 9335 3Standard Septic Shock Treatments Ineffective 9335 4
... global health threat. Although more than 3 billio...to fight tuberculosis, the ability of the BCG vacc...fficacy against newly emerging isolates. , In a st...int publication of the September 1 issue of the Jo...nd colleagues from the Max Planck Institute devise...
...in HIV-infected patients at the time of HIV diagno...ife expectancy, according to an article in the Nov...ilable online. , Resistance to antiretroviral the...atment, is a growing concern. However, genotype re...resence of resistance genes, is not a standard pro...
...ard off a cliff. Another prefers to read a book an...erences exist is a mystery, but for the first time...planation behind risk-seeking behavior. , Scienti... found that a specific neurodevelopmental gene, ca...almond-shaped area of the brain called the amygdal...
...ificial shark skin could help ships sailing smooth...es on ship hulls is a major cause of increased ene... a structural design that prevents this so called ... of Applied Sciences, Bremen, Germany, is presenti... skin in a new anti-fouling strategy at the Societ...
Other Biology News:Drug resistance testing in treatment-naive HIV patients is cost-effective 2Study identifies gene in mice that may control risk-taking behavior in humans 2Study identifies gene in mice that may control risk-taking behavior in humans 3
Request Info
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis.
Please email us with project details and we will respond within 24 hours to your query!
Request Info
Biology Products: